Introduction
This report is the third annual ESHRE publication on European data on assisted reproduction technology (ART). The two previous reports, also published in Human Reproduction (ESHRE, 2001a , ESHRE, 2001b , covered treatment cycles during 1997 and 1998.
Data has been collected from 22 European countries and covers IVF, ICSI, frozen embryo replacements (FER) and oocyte donations (OD) initiated during 1999. Data from each participating country is sent to ESHRE yearly. A draft report is made and scrutinized by all consortium members, listed in the Appendix at the end of this paper.
A second Consortium meeting was held at the ESHRE meeting in Vienna in July 2002 with representatives from participating countries, where the present and future reporting system was discussed. Here it was noted that Germany reported a marked increased in the coverage in their register. Belgium, Hungary and Switzerland were planning to advance Greece, Ireland, Italy, Poland, Slovenia and Ukraine where no such register existed, national data was collected de novo for the purpose of the EIM programme. Details regarding the registers have been described earlier (ESHRE, 2001a) .
Data collection
The present report summarizes data from ART treatments started during 1999. The data include treatments from IVF, ICSI, OD and FER performed from January 1, 1999 to December 31, 1999. Followup data on pregnancies and deliveries are cohort data.
The data collection programmes vary considerably from one country to another. Registers from a number of countries have been unable to provide some of the data. Lack of such specific variables will appear in the tables as 'not available' (NA).
The reporting principle used for the 1999 data is basically similar to the preceding year (ESHRE, 2001a,b) . The following eight countries reported data from all clinics in the country: Denmark, Finland, France, Iceland, The Netherlands, Norway, Sweden and Switzerland. In 1998 the UK also reported data from all clinics. In 1999 technical problems within the Human Fertilisation and Embryology Authority (HFEA) had the consequence that only data from a proportion of the clinics were incorporated, and some data were not available.
For 1999, the report includes summary data on complications such as ovarian hyperstimulation syndrome (OHSS), infection and bleeding. Furthermore, data on preimplantation genetic diagnosis (PGD) are also available.
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Deliveries were normally reported within the same reporting system as for treatments and pregnancies. For the present report neither the definitions of pregnancies or births have been standardized. As the data presented here is incomplete and generated through different methods using different definitions in different countries, interpretation of the data must be done with some caution. Table I shows the number of all treatment cycles recorded in each country, the number of clinics in the country (if available) and the number and size of clinics reporting to the register. The cycles are subdivided into IVF, ICSI, FER and OD. In Belgium, Iceland and Slovenia the number of aspirations were used, as the number of initiated cycles were not available. In total 538 clinics from 22 countries reported 258 460 cycles. Table II shows data from those eight countries where all clinics reported to the register: Denmark, Finland, France, Iceland, The Netherlands, Norway, Sweden and Switzerland. The number of cycles are related to the total population in the country and to the female populations aged 15-49 years. In addition, the number of infants born after ART is expressed as a percentage of the total number of live-born in the country. Overall 99 629 cycles were undertaken in a population of 105.7 million, giving a mean of 943 cycles per million and 3.9 cycles per 1000 women aged 15-49. The percentage of infants born after ART was 1.6% on average and ranged from 0.7-3.6%. If Switzerland, where there is a large loss of follow-up of pregnancies, is excluded, the percentage of children born after ART was 1.7%, with a range from 1.4-3.6%. Table III shows the size distribution of the 538 reporting clinics. The size of a clinic (or unit) is based on all cycles performed per year. Table IV shows the age distribution of the treated women in various countries. In the different countries the age range of women Ͻ29 years was 6-45%; 30-34 years 31-44%; 35-39 years 18-44% and ജ40 years 4-18%. 
Results

Number of treatment cycles
Size of the clinics
Age distribution
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Number of embryos transferred Table V shows the number of embryos transferred after IVF and ICSI combined. The total number of single embryo transfers was 15 881 (11.9%), dual embryo transfers 52 113 (39.2%), triple embryo transfers 52 646 (39.6%) and ജ4 embryo transfers 12 395 (9.3%). As indicated in the Table, wide differences were seen between countries. The range of triple embryo transfers was 4.5-67.3% and the range of transfer of ജ4 embryos was 0.0-59.5%.
Pregnancies and deliveries after treatment
Tables VI-IX show the number of pregnancies and deliveries in relation to the number of initiated cycles, aspirations and transfers for IVF (Table VI) , ICSI (Table VII) , FER (Table  VIII) and OD (Table IX) . Table VI shows that after IVF the 27 196 pregnancies resulted from 98 313 embryo transfers. Thus, the mean clinical pregnancy rate per embryo transfer was 27.7%, with a range Table X shows the deliveries after IVF and ICSI in relation to singleton, twin, triplet and quadruplet deliveries. It can be seen that the distribution of the deliveries was: singleton 73.7%, twin 24.0%, triplet 2.2% and quadruplet 0.1%. Table XI shows the deliveries after FER in relation to singleton, twin, triplet and quadruplet deliveries. It is seen that the distribution of the deliveries was: singleton 84.8%, twin 14.0%, triplet 0.8% and quadruplet 0.4%. Table XII shows the proportion of infants born as singletons, twins, triplets and quadruplets after IVF and ICSI treatment. 
Singleton, twin, triplet and quadruplet deliveries
Pregnancies per embryo
Table XIII presents calculations on the number of clinical pregnancies per embryo replaced after IVF and ICSI. The same parameter can also be expressed as the number of embryos replaced in order to achieve one clinical pregnancy (embryos/pregnancy). It is seen that on average the number of 3265 pregnancies per embryo was 0.13 and the number of embryos used to achieve one clinical pregnancy was 7.8. 
OHSS
Maternal death
One case of maternal death was recorded.
Discussion
The present report is the third consecutive European report on IVF data covering treatment cycles from 1997, 1998 and 1999 
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Eight of the participating countries already have complete coverage in their reporting systems: Denmark, Finland, France, Iceland, The Netherlands, Norway, Sweden and Switzerland. Germany has improved its coverage, which is now estimated to include around 90% of the activities in that country. Belgium, Hungary and Switzerland have announced the plan to advance their systems into mandatory registers.
The number of reported cycles continues to grow. This year Within Europe the largest contributions come from Germany with 60 000 cycles followed by France with 52 000 cycles and the UK with 30 000 reported cycles. It should be noted that the figure from the UK is lower compared with previous years due to technical problems in their reporting system.
The proportion of standard IVF procedures to ICSI procedures remains the same this year compared with last year (56.6% standard IVF and 43.4% ICSI), but in some countries such as Belgium, Greece, Italy, Poland, Portugal, Spain and Switzerland ICSI is more prevalent than IVF. The number of FER cycles remained constant whereas the number of OD cycles showed a small decrease.
The availability of services remained highest in Denmark with 1659 cycles per million inhabitants. It was also high in the other Nordic countries, in The Netherlands and in France. The average number of treatment cycles per million inhabitants in those countries with complete coverage in their reporting was a little below 1000. The proportion of IVF children to all children born was again highest in the Nordic countries with Iceland at 3.6%, Denmark 3.2%, Finland 2.7% and Sweden 2.6%.
The number of embryos transferred in IVF and ICSI cycles differed substantially between countries. The mean number of 3268 single embryo transfers remained at about 12%, whereas the proportion of dual embryo transfers increased to 39.2% (compared with 37.2% and 35.7% for 1998 and 1997 respectively). The proportion of three embryo transfers was 39.6%, representing a small decrease from the previous year where it was 42.0%. Four embryo transfers or more remained constant at 9.3%. Finland, Sweden and Slovenia reported no embryo transfers of ജ4, and also a low proportion of three embryo transfers, whereas some other countries still reported very high proportions of ജ4 embryos transferred.
Pregnancy rates continued to increase slightly. For standard IVF the mean pregnancy rate per transfer was 27.7% (compared with 27.0% for 1998), for ICSI 27.9% (versus 26.8%), for FER cycles 15.7% (versus 14.9%) and for OD cycles 40.0% (versus 30.6% for 1998). Again there were quite large differences between different countries. As an example the pregnancy rate per transfer for IVF cycles varied between 22.7-42.3%.
Delivery rates showed similar trends but one problem remains: in some countries the lost to follow-up rate for deliveries is quite high. Therefore, delivery rates are less valid when compared with pregnancy rates.
One other possibility for reporting success rates would be to report on singleton delivery rates separately. The consortium plans to do so, as soon as the delivery rates are more valid. If only singleton pregnancies are accepted as a success, onlỹ 20% of transfers resulted in a successful outcome. The occurrence of multiple deliveries did not change from 1998 (26.3%) to 1999 (26.3%). Neither did the twin or the triplet rate change from 1998 to 1999. The triplet rate remained at 2.2% of all deliveries, so the reduction seen from 1997 to 1998 did not continue.
The proportion of singleton deliveries after IVF and ICSI varied between countries within a range of 60.8-83.3%, twin rates from 10.8-32.5% and triplet rates from 0.3-6.4%. The practice of fetal reduction is very different in different European countries. In some it is quite often practised whereas in others it is not practised at all. The consortium has not, so far, been able to collect reliable data on fetal reductions but is planning to do so in future reports. The proportion of infants (rather than deliveries) for singletons varied from 42-79%, for twins between 19-44% and for triplets between 0.6-15%. The proportion of quadruplets was very low.
Alternative ways of presenting success rates for the whole of Europe showed a pregnancy rate of 0.13 per embryo replaced and that 7.8 embryos needed to be replaced to obtain one pregnancy. These calculations include both singleton and multiple pregnancies.
In this report, for the first time, data on OHSS was collected. Data was not available from all countries. From those reporting, the overall proportion of OHSS was close to 1% with a high of 2.7% and a low of 0.3%. Of course various definitions and also various clinical policies make comparisons difficult.
Altogether 131 aspirations were followed by PGD, and of these 19 babies were delivered. It is expected that these activities will expand in the future. Certainly, a proportion of countries perform PGD, that are not reported within the EIM.
To summarize, this third ESHRE report on IVF cycles carried out in 1999 in Europe shows a continuing expansion of the register, both for participating countries, participating clinics and number of cycles reported. Trends are now becoming visible and there is a trend towards better efficacy. The combined multiple pregnancy rate was reduced from 1997 to 1998, but no further reduction was recorded from 1998 to 1999. With new knowledge on the safety of these procedures it becomes increasingly obvious that the proportion of multiple pregnancies is still much too high, although, at present, quite different in different European countries.
